Expansion from tx.fhir.org based on:

This value set cannot be fully expanded, but a selection (293 codes) of the whole set of codes is shown here.

System	Code	Display (en)	Inactive	Definition	JSON	XML
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_MedicationObservationType	MedicationObservationType
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0SPLSHAPE	shape		Description: A characteristic of an oral solid dosage form of a medicinal product, specifying the two dimensional representation of the solid dose form, in terms of the outside perimeter of a solid dosage form when the dosage form, resting on a flat surface, is viewed from directly above, including slight rounding of corners. SPLSHAPE does not include embossing, scoring, debossing, or internal cut-outs. SPLSHAPE is independent of the orientation of the imprint and logo. Shapes can include: Triangle (3 sided); Square; Round; Semicircle; Pentagon (5 sided); Diamond; Double circle; Bullet; Hexagon (6 sided); Rectangle; Gear; Capsule; Heptagon (7 sided); Trapezoid; Oval; Clover; Octagon (8 sided); Tear; Freeform. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0SPLCOATING	coating		Definition: A characteristic of an oral solid dosage form of a medicinal product, indicating whether it has one or more coatings such as sugar coating, film coating, or enteric coating. Only coatings to the external surface or the dosage form should be considered (for example, coatings to individual pellets or granules inside a capsule or tablet are excluded from consideration). \n Constraints: The Observation.value must be a Boolean (BL) with true for the presence or false for the absence of one or more coatings on a solid dosage form. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0SPLIMPRINT	imprint		Definition: A characteristic of an oral solid dosage form of a medicinal product, specifying the alphanumeric text that appears on the solid dosage form, including text that is embossed, debossed, engraved or printed with ink. The presence of other non-textual distinguishing marks or symbols is recorded by SPLSYMBOL. \n Examples: Included in SPLIMPRINT are alphanumeric text that appears on the bands of banded capsules and logos and other symbols that can be interpreted as letters or numbers. \n Constraints: The Observation.value must be of type Character String (ST). Excluded from SPLIMPRINT are internal and external cut-outs in the form of alphanumeric text and the letter 'R' with a circle around it (when referring to a registered trademark) and the letters 'TM' (when referring to a 'trade mark'). To record text, begin on either side or part of the dosage form. Start at the top left and progress as one would normally read a book. Enter a semicolon to show separation between words or line divisions. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0SPLSCORING	scoring		Definition: A characteristic of an oral solid dosage form of a medicinal product, specifying the number of equal pieces that the solid dosage form can be divided into using score line(s). \n Example: One score line creating two equal pieces is given a value of 2, two parallel score lines creating three equal pieces is given a value of 3. \n Constraints: Whether three parallel score lines create four equal pieces or two intersecting score lines create two equal pieces using one score line and four equal pieces using both score lines, both have the scoring value of 4. Solid dosage forms that are not scored are given a value of 1. Solid dosage forms that can only be divided into unequal pieces are given a null-value with nullFlavor other (OTH). \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0REP_HALF_LIFE	representative half-life		Description:This observation represents an 'average' or 'expected' half-life typical of the product. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0SPLIMAGE	image		Description: A characteristic representing a single file reference that contains two or more views of the same dosage form of the product; in most cases this should represent front and back views of the dosage form, but occasionally additional views might be needed in order to capture all of the important physical characteristics of the dosage form. Any imprint and/or symbol should be clearly identifiable, and the viewer should not normally need to rotate the image in order to read it. Images that are submitted with SPL should be included in the same directory as the SPL file. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0SPLSIZE	size		Definition: A characteristic of an oral solid dosage form of a medicinal product, specifying the longest single dimension of the solid dosage form as a physical quantity in the dimension of length (e.g., 3 mm). The length is should be specified in millimeters and should be rounded to the nearest whole millimeter. \n Example: SPLSIZE for a rectangular shaped tablet is the length and SPLSIZE for a round shaped tablet is the diameter. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0SPLCOLOR	color		Definition: A characteristic of an oral solid dosage form of a medicinal product, specifying the color or colors that most predominantly define the appearance of the dose form. SPLCOLOR is not an FDA specification for the actual color of solid dosage forms or the names of colors that can appear in labeling. \n Constraints: The Observation.value must be a single coded value or a list of multiple coded values, specifying one or more distinct colors that approximate of the color(s) of distinct areas of the solid dosage form, such as the different sides of a tablet or one-part capsule, or the different halves of a two-part capsule. Bands on banded capsules, regardless of the color, are not considered when assigning an SPLCOLOR. Imprints on the dosage form, regardless of their color are not considered when assigning an SPLCOLOR. If more than one color exists on a particular side or half, then the most predominant color on that side or half is recorded. If the gelatin capsule shell is colorless and transparent, use the predominant color of the contents that appears through the colorless and transparent capsule shell. Colors can include: Black;Gray;White;Red;Pink;Purple;Green;Yellow;Orange;Brown;Blue;Turquoise. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0SPLSYMBOL	symbol		Definition: A characteristic of an oral solid dosage form of a medicinal product, to describe whether or not the medicinal product has a mark or symbol appearing on it for easy and definite recognition. Score lines, letters, numbers, and internal and external cut-outs are not considered marks or symbols. See SPLSCORING and SPLIMPRINT for these characteristics. \n Constraints: The Observation.value must be a Boolean (BL) with <u>true</u> indicating the presence and <u>false</u> for the absence of marks or symbols. \n Example: \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ObservationSeriesType	ObservationSeriesType
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ECGObservationSeriesType	ECGObservationSeriesType
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0RHYTHM	ECG rhythm waveforms		This Observation type contains ECG "rhythm" waveforms. The waveform samples are measured in absolute time (a.k.a. "subject time" or "effective time"). These waveforms are usually "raw" with some minimal amount of noise reduction and baseline filtering applied. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0REPRESENTATIVE_BEAT	ECG representative beat waveforms		This Observation Series type contains waveforms of a "representative beat" (a.k.a. "median beat" or "average beat"). The waveform samples are measured in relative time, relative to the beginning of the beat as defined by the Observation Series effective time. The waveforms are not directly acquired from the subject, but rather algorithmically derived from the "rhythm" waveforms. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_PatientCharacteristicObservationType	PatientCharacteristicObservationType	inactive	Indicates the type of characteristics a patient should have for a given therapy to be appropriate. E.g. Weight, Age, certain lab values, etc. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ObservationSequenceType	ObservationSequenceType
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ECGObservationSequenceType	ECGObservationSequenceType	inactive
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0TIME_ABSOLUTE	absolute time sequence		A sequence of values in the "absolute" time domain. This is the same time domain that all HL7 timestamps use. It is time as measured by the Gregorian calendar \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0TIME_RELATIVE	relative time sequence		A sequence of values in a "relative" time domain. The time is measured relative to the earliest effective time in the Observation Series containing this sequence. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DX	ObservationDiagnosisTypes		Includes all codes defining types of indications such as diagnosis, symptom and other indications such as contrast agents for lab tests. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0NOI	nature of injury		The type of injury that the injury coding specifies. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ADMDX	admitting diagnosis		Admitting diagnosis are the diagnoses documented for administrative purposes as the basis for a hospital admission. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0INTDX	intermediate diagnosis		Intermediate diagnoses are those diagnoses documented for administrative purposes during the course of a hospital stay. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DISDX	discharge diagnosis		Discharge diagnosis are the diagnoses documented for administrative purposes as the time of hospital discharge. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0GENE	gene		Description: A DNA segment that contributes to phenotype/function. In the absence of demonstrated function a gene may be characterized by sequence, transcription or homology \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_IndividualCaseSafetyReportType	Individual Case Safety Report Type		A code that is used to indicate the type of case safety report received from sender. The current code example reference is from the International Conference on Harmonisation (ICH) Expert Workgroup guideline on Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports. The unknown/unavailable option allows the transmission of information from a secondary sender where the initial sender did not specify the type of report. \n Example concepts include: Spontaneous, Report from study, Other. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0PAT_ADV_EVNT	patient adverse event		Indicates that the ICSR is describing problems that a patient experienced after receiving a vaccine product. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0VAC_PROBLEM	vaccine product problem		Indicates that the ICSR is describing a problem with the actual vaccine product such as physical defects (cloudy, particulate matter) or inability to confer immunity. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ObservationVisionPrescriptionType	ObservationVisionPrescriptionType	inactive	Definition: Identifies the type of Vision Prescription Observation that is being described. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_AnnotationType	AnnotationType
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ECGAnnotationType	ECGAnnotationType	inactive
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ActPatientAnnotationType	ActPatientAnnotationType		Description:Provides a categorization for annotations recorded directly against the patient . \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ANNGEN	general note		Description:A general or uncategorized note. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ANNIMM	immunization note		A note that is specific to a patient's immunizations, either historical, current or planned. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ANNDI	diagnostic image note		Description:A note that is specific to a patient's diagnostic images, either historical, current or planned. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ANNLAB	laboratory note		Description:A note that is specific to a patient's laboratory results, either historical, current or planned. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ANNMED	medication note		Description:A note that is specific to a patient's medications, either historical, current or planned. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_CommonClinicalObservationType	CommonClinicalObservationType	inactive	Used in a patient care message to report and query simple clinical (non-lab) observations. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0GISTIER	GIS tier		Description: Accuracy determined as per the GIS tier code system. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0HHOBS	household situation observation		Indicates that the observation is of a person’s living situation in a household including the household composition and circumstances. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_PopulationInclusionObservationType	PopulationInclusionObservationType		Observation types for specifying criteria used to assert that a subject is included in a particular population. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DENEXCEP	denominator exceptions		Criteria which specify the removal of a subject, procedure or unit of measurement from the denominator, only if the numerator criteria are not met. Denominator exceptions allow for adjustment of the calculated score for those providers with higher risk populations. Denominator exceptions are used only in proportion eMeasures. They are not appropriate for ratio or continuous variable eMeasures. Denominator exceptions allow for the exercise of clinical judgment and should be specifically defined where capturing the information in a structured manner fits the clinical workflow. Generic denominator exception reasons used in proportion eMeasures fall into three general categories: \n \n Medical reasons \n Patient (or subject) reasons \n System reasons \n \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MSROBS	measure observation		Defines the observation to be performed for each patient or event in the measure population. Measure observations for each case in the population are aggregated to determine the overall measure score for the population. \n Examples: \n \n the median time from arrival in the Emergency Room to departure \n the median time from decision to admit to a hospital to the actual admission for Emergency Room patients \n \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MSRPOPL	measure population		Criteria for specifying the measure population as a narrative description (e.g., all patients seen in the Emergency Department during the measurement period). This is used only in continuous variable eMeasures. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MSRPOPLEX	measure population exclusions		Criteria for specifying subjects who should be removed from the eMeasure's Initial Population and Measure Population. Measure Population Exclusions are used in Continuous Variable measures to help narrow the Measure Population before determining the value(s) of the continuous variable(s). \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DENEX	denominator exclusions		Criteria which specify subjects who should be removed from the eMeasure population and denominator before determining if numerator criteria are met. Denominator exclusions are used in proportion and ratio measures to help narrow the denominator. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DENOM	denominator		Criteria for specifying the entities to be evaluated by a specific quality measure, based on a shared common set of characteristics (within a specific measurement set to which a given measure belongs). The denominator can be the same as the initial population, or it may be a subset of the initial population to further constrain it for the purpose of the eMeasure. Different measures within an eMeasure set may have different denominators. Continuous Variable eMeasures do not have a denominator, but instead define a measure population. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0NUMER	numerator		Criteria for specifying the processes or outcomes expected for each patient, procedure, or other unit of measurement defined in the denominator for proportion measures, or related to (but not directly derived from) the denominator for ratio measures (e.g., a numerator listing the number of central line blood stream infections and a denominator indicating the days per thousand of central line usage in a specific time period). \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0NUMEX	numerator exclusions		Criteria for specifying instances that should not be included in the numerator data. (e.g., if the number of central line blood stream infections per 1000 catheter days were to exclude infections with a specific bacterium, that bacterium would be listed as a numerator exclusion). Numerator Exclusions are used only in ratio eMeasures. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0IPOP	initial population		Criteria for specifying the entities to be evaluated by a specific quality measure, based on a shared common set of characteristics (within a specific measurement set to which a given measure belongs). \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0IPPOP	initial patient population		Criteria for specifying the patients to be evaluated by a specific quality measure, based on a shared common set of characteristics (within a specific measurement set to which a given measure belongs). Details often include information based upon specific age groups, diagnoses, diagnostic and procedure codes, and enrollment periods. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ActSpecObsCode	ActSpecObsCode		Identifies the type of observation that is made about a specimen that may affect its processing, analysis or further result interpretation \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ARTBLD	ActSpecObsArtBldCode		Describes the artificial blood identifier that is associated with the specimen. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0EVNFCTS	ActSpecObsEvntfctsCode		Domain provides codes that qualify the ActLabObsEnvfctsCode domain. (Environmental Factors) \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DILUTION	ActSpecObsDilutionCode		An observation that reports the dilution of a sample. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0PRE	Pre-Dilution		The dilution of the specimen made prior to being loaded onto analytical equipment \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0AUTO-HIGH	Auto-High Dilution		The dilution of a sample performed by automated equipment. The value is specified by the equipment \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0AUTO-LOW	Auto-Low Dilution		The dilution of a sample performed by automated equipment. The value is specified by the equipment \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0RERUN	Rerun Dilution		The value of the dilution of a sample after it had been analyzed at a prior dilution value \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0INTFR	ActSpecObsInterferenceCode		An observation that relates to factors that may potentially cause interference with the observation \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FIBRIN	Fibrin		The Fibrin Index of the specimen. In the case of only differentiating between Absent and Present, recommend using 0 and 1 \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0HEMOLYSIS	Hemolysis		An observation of the hemolysis index of the specimen in g/L \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0LIPEMIA	Lipemia		An observation used to describe the Lipemia Index of the specimen. It is recommended to use the optical turbidity at 600 nm (in absorbance units). \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ICTERUS	Icterus		An observation that describes the icterus index of the specimen. It is recommended to use mMol/L of bilirubin \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0VOLUME	ActSpecObsVolumeCode		An observation that reports the volume of a sample. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0CURRENT	Current Volume		The current quantity of the specimen, i.e., initial quantity minus what has been actually used. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0INITIAL	Initial Volume		The initial quantity of the specimen in inventory \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0CONSUMPTION	Consumption Volume		The quantity of specimen that is used each time the equipment uses this substance \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0AVAILABLE	Available Volume		The available quantity of specimen. This is the current quantity minus any planned consumption (e.g., tests that are planned) \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0SEV	Severity Observation		A subjective evaluation of the seriousness or intensity associated with another observation. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ImmunizationObservationType	ImmunizationObservationType		Description: Observation codes which describe characteristics of the immunization material. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0OBSANTC	antigen count		Description: Indicates the valid antigen count. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0OBSANTV	antigen validity		Description: Indicates whether an antigen is valid or invalid. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ObservationCausalityAssessmentType	observation causality assessment	inactive	Description:A kind of observation that allows a Secondary Observation (source act) to assert (at various levels of probability) that the target act of the association (which may be of any type of act) is implicated in the etiology of another observation that is named as the subject of the Secondary Observation \n Example:Causality assertions where an accident is the cause of a symptom; predisposition assertions where the genetic state plus environmental factors are implicated in the development of a disease; reaction assertions where a substance exposure is associated with a finding of wheezing. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ObservationAllergyTestCode	observation allergy test	inactive	Description:Dianostic procedures ordered or performed to evaluate whether a sensitivity to a substance is present. This test may be associated with specimen collection and/or substance administration challenge actiivities. \n Example:Skin tests and eosinophilia evaluations. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_LOINCObservationActContextAgeType	LOINCObservationActContextAgeType		Definition:The set of LOINC codes for the act of determining the period of time that has elapsed since an entity was born or created. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a021611-9	age patient qn est		Definition:Estimated age. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a029553-5	age patient qn calc		Definition:Calculated age. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a021612-7	age patient qn reported		Definition:Reported age. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a030972-4	age at onset of adverse event		Definition:Age at onset of associated adverse event; no implied method of determination. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a030525-0	age patient qn definition		Definition:General specification of age with no implied method of determination. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ASSERTION	Assertion		Description:Refines classCode OBS to indicate an observation in which observation.value contains a finding or other nominalized statement, where the encoded information in Observation.value is not altered by Observation.code. For instance, observation.code="ASSERTION" and observation.value="fracture of femur present" is an assertion of a clinical finding of femur fracture. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ObservationIndicationType	ObservationIndicationType	inactive	Includes all codes defining types of indications such as diagnosis, symptom and other indications such as contrast agents for lab tests \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_AdverseSubstanceAdministrationEventActionTakenType	AdverseSubstanceAdministrationEventActionTakenType	inactive	Definition: Indicates the class of actions taken with regard to a substance administration related adverse event. This characterization offers a judgment of the practitioner's response to the patient's problem. \n Examples: Example values include dose withdrawn, dose reduced, dose not changed. \n NOTE: The concept domain is currently supported by a value set created by the International Conference on Harmonization \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_CaseTransmissionMode	case transmission mode		Code for the mechanism by which disease was acquired by the living subject involved in the public health case. Includes sexually transmitted, airborne, bloodborne, vectorborne, foodborne, zoonotic, nosocomial, mechanical, dermal, congenital, environmental exposure, indeterminate. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ANHUMTRNS	animal to human transmission		Communication of an agent from an animal to a proximate person. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0HUMHUMTRNS	human to human transmission		Communication of an agent from a person to a proximate person. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0TRNSFTRNS	transfusion transmission		Communication of an agent from one living subject to another living subject through direct contact with blood or blood products where the contact with blood is part of a therapeutic procedure. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0AIRTRNS	airborne transmission		Communication of an agent from a living subject or environmental source to a living subject through indirect contact via oral or nasal inhalation. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0BLDTRNS	blood borne transmission		Communication of an agent to a living subject through direct contact with blood or blood products whether the contact with blood is part of a therapeutic procedure or not. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ENVTRNS	environmental exposure transmission		Communication of an agent from an environmental surface or source to a living subject by direct contact. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FECTRNS	fecal-oral transmission		Communication of an agent from a living subject or environmental source to a living subject through oral contact with material contaminated by person or animal fecal material. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FOMTRNS	fomite transmission		Communication of an agent from an non-living material to a living subject through direct contact. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0INDTRNS	indeterminate disease transmission mode		Communication of an agent to a living subject via an undetermined route. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0LACTTRNS	lactation transmission		Communication of an agent from one living subject to another living subject through direct contact with mammalian milk or colostrum. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ANANTRNS	animal to animal transmission		Communication of an agent from one animal to another proximate animal. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DERMTRNS	transdermal transmission		Communication of an agent from a living subject or environmental source to a living subject via agent migration through intact skin. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FOODTRNS	food-borne transmission		Communication of an agent from a food source to a living subject via oral consumption. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0NOSTRNS	nosocomial transmission		Communication of an agent from any entity to a living subject while the living subject is in the patient role in a healthcare facility. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0PARTRNS	parenteral transmission		Communication of an agent from a living subject or environmental source to a living subject where the acquisition of the agent is not via the alimentary canal. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0PLACTRNS	transplacental transmission		Communication of an agent from a living subject to the progeny of that living subject via agent migration across the maternal-fetal placental membranes while in utero. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0SEXTRNS	sexual transmission		Communication of an agent from one living subject to another living subject through direct contact with genital or oral tissues as part of a sexual act. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0VECTRNS	vector-borne transmission		Communication of an agent from a living subject acting as a required intermediary in the agent transmission process to a recipient living subject via direct contact. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0WATTRNS	water-borne transmission		Communication of an agent from a contaminated water source to a living subject whether the water is ingested as a food or not. The route of entry of the water may be through any bodily orifice. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0BDYFLDTRNS	body fluid contact transmission		Communication of an agent from one living subject to another living subject through direct contact with any body fluid. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ObservationDiagnosisTypes	ObservationDiagnosisTypes	inactive	Includes all codes defining types of indications such as diagnosis, symptom and other indications such as contrast agents for lab tests. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0CDIO	case disease imported observation		An observation that states whether the disease was likely acquired outside the jurisdiction of observation, and if so, the nature of the inter-jurisdictional relationship. \n OpenIssue: This code could be moved to LOINC if it can be done before there are significant implemenations using it. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_PatientImmunizationRelatedObservationType	PatientImmunizationRelatedObservationType		Description: Reporting codes that are related to an immunization event. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0GRADE	grade		Description: The school grade or level the patient was in when immunized. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0SCHLDIV	school division		Description: The school division or district associated with the patient during the immunization event. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0SCHL	school		Description: The school the patient attended when immunized. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0TEACHER	teacher		Description: The patient's teacher when immunized. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0CLSSRM	classroom		Description: The class room associated with the patient during the immunization event. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ObservationGenomicFamilyHistoryType	ObservationGenomicFamilyHistoryType	inactive
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0OINT	intolerance		Hypersensitivity resulting in an adverse reaction upon exposure to an agent. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ALG	Allergy		Hypersensitivity to an agent caused by an immunologic response to an initial exposure \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DALG	Drug Allergy		An allergy to a pharmaceutical product. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FALG	Food Allergy		An allergy to a substance generally consumed for nutritional purposes. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0EALG	Environmental Allergy		An allergy to a substance other than a drug or a food. E.g. Latex, pollen, etc. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DINT	Drug Intolerance		Hypersensitivity resulting in an adverse reaction upon exposure to a drug. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DNAINT	Drug Non-Allergy Intolerance		Hypersensitivity to an agent caused by a mechanism other than an immunologic response to an initial exposure \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FINT	Food Intolerance		Hypersensitivity resulting in an adverse reaction upon exposure to food. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FNAINT	Food Non-Allergy Intolerance		Hypersensitivity to an agent caused by a mechanism other than an immunologic response to an initial exposure \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0EINT	Environmental Intolerance		Hypersensitivity resulting in an adverse reaction upon exposure to environmental conditions. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ENAINT	Environmental Non-Allergy Intolerance		Hypersensitivity to an agent caused by a mechanism other than an immunologic response to an initial exposure \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0NAINT	Non-Allergy Intolerance		Hypersensitivity to an agent caused by a mechanism other than an immunologic response to an initial exposure \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ObservationAllergyTestType	ObservationAllergyTestType	inactive	Indicates the type of allergy test performed or to be performed. E.g. the specific antibody or skin test performed \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ObservationDosageDefinitionPreconditionType	observation dosage definition precondition type	inactive	Definition: \n The set of observation type concepts that can be used to express pre-conditions to a particular dosage definition. \n Rationale: Used to constrain the set of observations to those related to the applicability of a dosage, such as height, weight, age, pregnancy, liver function, kidney function, etc. For example, in drug master-file type records indicating when a specified dose is applicable. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ObservationQualityMeasureAttribute	ObservationQualityMeasureAttribute		Codes used to define various metadata aspects of a health quality measure. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0CRS	clinical recommendation statement		Summary of relevant clinical guidelines or other clinical recommendations supporting this eMeasure. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MSRADJ	risk adjustment		The method of adjusting for clinical severity and conditions present at the start of care that can influence patient outcomes for making valid comparisons of outcome measures across providers. Indicates whether an eMeasure is subject to the statistical process for reducing, removing, or clarifying the influences of confounding factors to allow more useful comparisons. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MSRAGG	rate aggregation		Describes how to combine information calculated based on logic in each of several populations into one summarized result. It can also be used to describe how to risk adjust the data based on supplemental data elements described in the eMeasure. (e.g., pneumonia hospital measures antibiotic selection in the ICU versus non-ICU and then the roll-up of the two). \n Open Issue: The description does NOT align well with the definition used in the HQMF specfication; correct the MSGAGG definition, and the possible distinction of MSRAGG as a child of AGGREGATE. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MSRIMPROV	health quality measure improvement notation		Information on whether an increase or decrease in score is the preferred result. This should reflect information on which way is better, an increase or decrease in score. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0TRANF	transmission format		Can be a URL or hyperlinks that link to the transmission formats that are specified for a particular reporting program. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DEF	definition		Description of individual terms, provided as needed. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MSRJUR	jurisdiction		The list of jurisdiction(s) for which the measure applies. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0KEY	keyword		A significant word that aids in discoverability. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DISC	disclaimer		Disclaimer information for the eMeasure. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MSD	measurement start date		The start date of the measurement period. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0RAT	rationale		Succinct statement of the need for the measure. Usually includes statements pertaining to Importance criterion: impact, gap in care and evidence. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0REF	reference		Identifies bibliographic citations or references to clinical practice guidelines, sources of evidence, or other relevant materials supporting the intent and rationale of the eMeasure. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MSRSET	health quality measure care setting		Location(s) in which care being measured is rendered \n Usage Note: MSRSET is used rather than RoleCode because the setting applies to what is being measured, as opposed to participating directly in the health quality measure documantion itself). \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0SDE	supplemental data elements		Comparison of results across strata can be used to show where disparities exist or where there is a need to expose differences in results. For example, Centers for Medicare & Medicaid Services (CMS) in the U.S. defines four required Supplemental Data Elements (payer, ethnicity, race, and gender), which are variables used to aggregate data into various subgroups. Additional supplemental data elements required for risk adjustment or other purposes of data aggregation can be included in the Supplemental Data Element section. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0STRAT	stratification		Describes the strata for which the measure is to be evaluated. There are three examples of reasons for stratification based on existing work. These include: (1) evaluate the measure based on different age groupings within the population described in the measure (e.g., evaluate the whole [age 14-25] and each sub-stratum [14-19] and [20-25]); (2) evaluate the eMeasure based on either a specific condition, a specific discharge location, or both; (3) evaluate the eMeasure based on different locations within a facility (e.g., evaluate the overall rate for all intensive care units and also some strata include additional findings [specific birth weights for neonatal intensive care units]). \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MSRRPTR	reporter type		Type of person or organization that is expected to report the issue. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0USE	notice of use		Usage notes. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0CMPMSRSCRWGHT	component measure scoring weight		An attribute of a quality measure describing the weight this component measure score is to carry in determining the overall composite measure final score. The value is real value greater than 0 and less than 1.0. Each component measure score will be multiplied by its CMPMSRSCRWGHT and then summed with the other component measures to determine the final overall composite measure score. The sum across all CMPMSRSCRWGHT values within a single composite measure SHALL be 1.0. The value assigned is scoped to the composite measure referencing this component measure only. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MSRTYPE	measure type		Indicates whether the eMeasure is used to examine a process or an outcome over time (e.g., Structure, Process, Outcome). \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0CMPMSRMTH	composite measure method		Indicates what method is used in a quality measure to combine the component measure results included in an composite measure. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ITMCNT	items counted		Describes the items counted by the measure (e.g., patients, encounters, procedures, etc.) \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0IDUR	improvement notation		Information on whether an increase or decrease in score is the preferred result (e.g., a higher score indicates better quality OR a lower score indicates better quality OR quality is within a range). \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MEDT	measurement end date		The end date of the measurement period. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0GUIDE	guidance		Used to allow measure developers to provide additional guidance for implementers to understand greater specificity than could be provided in the logic for data criteria. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MSRSCORE	measure scoring		Indicates how the calculation is performed for the eMeasure (e.g., proportion, continuous variable, ratio) \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0COPY	copyright		Identifies the organization(s) who own the intellectual property represented by the eMeasure. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FINALDT	finalized date/time		The timestamp when the eMeasure was last packaged in the Measure Authoring Tool. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MSRTP	measurement period		The time period for which the eMeasure applies. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MSRTOPIC	health quality measure topic type
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0AGGREGATE	aggregate measure observation		Indicates that the observation is carrying out an aggregation calculation, contained in the value element. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MSRRPTTIME	timeframe for reporting		The maximum time that may elapse following completion of the measure until the measure report must be sent to the receiver. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0CRIT	criticality		A clinical judgment as to the worst case result of a future exposure (including substance administration). When the worst case result is assessed to have a life-threatening or organ system threatening potential, it is considered to be of high criticality. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0CASESER	case seriousness criteria		Definition:An observation that provides a characterization of the level of harm to an investigation subject as a result of a reaction or event. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ISSUE	detected issue		There is a clinical issue for the therapy that makes continuation of the therapy inappropriate. \n Open Issue: The definition of this code does not correctly represent the concept space of its specializations (children) \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ActAdministrativeDetectedIssueCode	ActAdministrativeDetectedIssueCode		Identifies types of detectyed issues for Act class "ALRT" for the administrative and patient administrative acts domains. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ActAdministrativeAuthorizationDetectedIssueCode	ActAdministrativeAuthorizationDetectedIssueCode
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0NAT	Insufficient authorization		The requesting party has insufficient authorization to invoke the interaction. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0VALIDAT	validation issue		Description:The specified element did not pass business-rule validation. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0BUS	business constraint violation		Description:A local business rule relating multiple elements has been violated. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0LEN_RANGE	length out of range		Description:The length of the data specified falls out of the range defined for the element. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0LEN_LONG	length is too long		Description:The length of the data specified is greater than the maximum length defined for the element. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0LEN_SHORT	length is too short		Description:The length of the data specified is less than the minimum length defined for the element. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSE	Dosage problem		Proposed dosage instructions for therapy differ from standard practice. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MDOSE	maximum dosage reached		Description:The maximum quantity of this drug allowed to be administered within a particular time-range (month, year, lifetime) has been reached or exceeded. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSEDUR	Dose-Duration Alert		Proposed length of therapy differs from standard practice. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSEDURH	Dose-Duration High Alert		Proposed length of therapy is longer than standard practice \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSEDURHIND	Dose-Duration High for Indication Alert		Proposed length of therapy is longer than standard practice for the identified indication or diagnosis \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSEDURL	Dose-Duration Low Alert		Proposed length of therapy is shorter than that necessary for therapeutic effect \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSEDURLIND	Dose-Duration Low for Indication Alert		Proposed length of therapy is shorter than standard practice for the identified indication or diagnosis \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSEIVL	Dose-Interval Alert		Proposed dosage interval/timing differs from standard practice \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSEIVLIND	Dose-Interval for Indication Alert		Proposed dosage interval/timing differs from standard practice for the identified indication or diagnosis \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSECOND	dosage-condition alert		Description:Proposed dosage is inappropriate due to patient's medical condition. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSEH	High Dose Alert		Proposed dosage exceeds standard practice \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSEHIND	High Dose for Indication Alert
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSEHINDSA	High Dose for Height/Surface Area Alert		Proposed dosage exceeds standard practice for the patient's height or body surface area \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSEHINDA	High Dose for Age Alert		Proposed dosage exceeds standard practice for the patient's age \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSEHINDW	High Dose for Weight Alert		Proposed dosage exceeds standard practice for the patient's weight \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSEL	Low Dose Alert		Proposed dosage is below suggested therapeutic levels \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSELIND	Low Dose for Indication Alert
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSELINDSA	Low Dose for Height/Surface Area Alert		Proposed dosage is below suggested therapeutic levels for the patient's height or body surface area \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSELINDA	Low Dose for Age Alert		Proposed dosage is below suggested therapeutic levels for the patient's age \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DOSELINDW	Low Dose for Weight Alert		Proposed dosage is below suggested therapeutic levels for the patient's weight \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FORMAT	invalid format		Description:The element does not follow the formatting or type rules defined for the field. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0KEY204	Unknown key identifier		The ID of the patient, order, etc., was not found. Used for transactions other than additions, e.g. transfer of a non-existent patient. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0KEY205	Duplicate key identifier		The ID of the patient, order, etc., already exists. Used in response to addition transactions (Admit, New Order, etc.). \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0NODUPS	duplicate values are not permitted		Description:More than one element with the same value exists in the set. Duplicates not permission in this set in a set. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0CODE_INVAL	code is not valid		Description:The specified code is not valid against the list of codes allowed for the element. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0CODE_DEPREC	code has been deprecated		Description:The specified code has been deprecated and should no longer be used. Select another code from the code system. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0OBSA	Observation Alert		Proposed therapy may be inappropriate or contraindicated due to conditions or characteristics of the patient \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0AGE	Age Alert		Proposed therapy may be inappropriate or contraindicated due to patient age \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ADALRT	adult alert		Proposed therapy is outside of the standard practice for an adult patient. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0GEALRT	geriatric alert		Proposed therapy is outside of standard practice for a geriatric patient. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0PEALRT	pediatric alert		Proposed therapy is outside of the standard practice for a pediatric patient. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0GEN	Genetic Alert		Proposed therapy may be inappropriate or contraindicated due to patient genetic indicators. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0LAB	Lab Alert		Proposed therapy may be inappropriate or contraindicated due to recent lab test results \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0CREACT	common reaction alert		Description:Proposed therapy may be inappropriate or contraindicated because of a common but non-patient specific reaction to the product. \n Example:There is no record of a specific sensitivity for the patient, but the presence of the sensitivity is common and therefore caution is warranted. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0REACT	Reaction Alert		Proposed therapy may be inappropriate or contraindicated based on the potential for a patient reaction to the proposed product \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0INT	Intolerance Alert		Proposed therapy may be inappropriate or contraindicated because of a recorded patient intolerance to the proposed product. (Intolerances are non-immune based sensitivities.) \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ALGY	Allergy Alert		Proposed therapy may be inappropriate or contraindicated because of a recorded patient allergy to the proposed product. (Allergies are immune based reactions.) \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0RREACT	Related Reaction Alert		Proposed therapy may be inappropriate or contraindicated because of a potential patient reaction to a cross-sensitivity related product. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0RALG	Related Allergy Alert		Proposed therapy may be inappropriate or contraindicated because of a recorded patient allergy to a cross-sensitivity related product. (Allergies are immune based reactions.) \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0RINT	Related Intolerance Alert		Proposed therapy may be inappropriate or contraindicated because of a recorded patient intolerance to a cross-sensitivity related product. (Intolerances are non-immune based sensitivities.) \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0RAR	Related Prior Reaction Alert		Proposed therapy may be inappropriate or contraindicated because of a recorded prior adverse reaction to a cross-sensitivity related product. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0GEND	Gender Alert		Proposed therapy may be inappropriate or contraindicated due to patient gender. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0COND	Condition Alert		Proposed therapy may be inappropriate or contraindicated due to an existing/recent patient condition or diagnosis \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0LACT	Lactation Alert		Proposed therapy may be inappropriate or contraindicated when breast-feeding \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0HGHT
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0PREG	Pregnancy Alert		Proposed therapy may be inappropriate or contraindicated during pregnancy \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0WGHT
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MISSMAND	mandatory element missing		Description:The specified element is mandatory and was not included in the instance. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ILLEGAL	illegal		Description:The request is missing elements or contains elements which cause it to not meet the legal standards for actioning. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MISSCOND	conditional element missing		Description:The specified element must be specified with a non-null value under certain conditions. In this case, the conditions are true but the element is still missing or null. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0COMPLY	Compliance Alert		There may be an issue with the patient complying with the intentions of the proposed therapy \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FRAUD	potential fraud		Description:The request is suspected to have a fraudulent basis. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DUPTHPY	Duplicate Therapy Alert		The proposed therapy appears to duplicate an existing therapy \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DUPTHPCLS	duplicate therapeutic alass alert		Description:The proposed therapy appears to have the same intended therapeutic benefit as an existing therapy, though the specific mechanisms of action vary. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DUPTHPGEN	duplicate generic alert		Description:The proposed therapy appears to have the same intended therapeutic benefit as an existing therapy and uses the same mechanisms of action as the existing therapy. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0PLYPHRM	Poly-supplier Alert		This patient was recently supplied a similar or identical therapy from a different pharmacy or supplier. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ABUSE	commonly abused/misused alert		Description:The proposed therapy is frequently misused or abused and therefore should be used with caution and/or monitoring. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0PLYDOC	Poly-orderer Alert		A similar or identical therapy was recently ordered by a different practitioner. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0NOPERSIST	element will not be persisted		Description: Element in submitted message will not persist in data storage based on detected issue. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0REP_RANGE	repetitions out of range		Description:The number of repeating elements falls outside the range of the allowed number of repetitions. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MAXOCCURS	repetitions above maximum		Description:The number of repeating elements is above the maximum number of repetitions allowed. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MINOCCURS	repetitions below minimum		Description:The number of repeating elements is below the minimum number of repetitions allowed. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0SUPPRESSED	record suppressed		Description: One or more records in the query response have been suppressed due to consent or privacy restrictions. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ActAdministrativeRuleDetectedIssueCode	ActAdministrativeRuleDetectedIssueCode
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0OBSOLETE	obsolete record returned		Description: One or more records in the query response have a status of 'obsolete'. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0KEY206	non-matching identification		Description: Metadata associated with the identification (e.g. name or gender) does not match the identification being verified. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ActSuppliedItemDetectedIssueCode	ActSuppliedItemDetectedIssueCode		Identifies types of detected issues regarding the administration or supply of an item to a patient. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0PATPREF	violates stated preferences		Definition:The proposed therapy goes against preferences or consent constraints recorded in the patient's record. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0PATPREFALT	violates stated preferences, alternate available		Definition:The proposed therapy goes against preferences or consent constraints recorded in the patient's record. An alternate therapy meeting those constraints is available. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_AdministrationDetectedIssueCode	AdministrationDetectedIssueCode		Administration of the proposed therapy may be inappropriate or contraindicated as proposed \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DACT	drug action detected issue		Description:Proposed therapy may be contraindicated or ineffective based on an existing or recent drug therapy. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_AppropriatenessDetectedIssueCode	AppropriatenessDetectedIssueCode
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_InteractionDetectedIssueCode	InteractionDetectedIssueCode
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FOOD	Food Interaction Alert		Proposed therapy may interact with certain foods \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0TPROD	Therapeutic Product Alert		Proposed therapy may interact with an existing or recent therapeutic product \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0DRG	Drug Interaction Alert		Proposed therapy may interact with an existing or recent drug therapy \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0NHP	Natural Health Product Alert		Proposed therapy may interact with existing or recent natural health product therapy \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0NONRX	Non-Prescription Interaction Alert		Proposed therapy may interact with a non-prescription drug (e.g. alcohol, tobacco, Aspirin) \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0PREVINEF	previously ineffective		Definition:The same or similar treatment has previously been attempted with the patient without achieving a positive effect. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_TimingDetectedIssueCode	TimingDetectedIssueCode	inactive	Proposed therapy may be inappropriate or ineffective based on the proposed start or end time. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0STRTLATE	Start Too Late Alert		Proposed therapy may be inappropriate or ineffective because the start of administration is too late after the onset of the condition \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ENDLATE	End Too Late Alert		Proposed therapy may be inappropriate or ineffective because the end of administration is too close to another planned therapy \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0TIME	timing detected issue		Description:Proposed therapy may be inappropriate or ineffective based on the proposed start or end time. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ALRTSTRTLATE	start too late alert		Definition:Proposed therapy may be inappropriate or ineffective because the start of administration is too late after the onset of the condition. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ALRTENDLATE	end too late alert		Definition:Proposed therapy may be inappropriate or ineffective because the end of administration is too close to another planned therapy. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_DrugActionDetectedIssueCode	DrugActionDetectedIssueCode	inactive	Proposed therapy may be contraindicated or ineffective based on an existing or recent drug therapy \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0HISTORIC	record recorded as historical		Description: While the record was accepted in the repository, there is a more recent version of a record of this type. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_SupplyDetectedIssueCode	SupplyDetectedIssueCode		Supplying the product at this time may be inappropriate or indicate compliance issues with the associated therapy \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0TOOLATE	Refill Too Late Alert		The patient is receiving a subsequent fill significantly later than would be expected based on the amount previously supplied and the therapy dosage instructions \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FULFIL	fulfillment alert		Definition:The therapy being performed is in some way out of alignment with the requested therapy. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0NOTACTN	no longer actionable		Definition:The status of the request being fulfilled has changed such that it is no longer actionable. This may be because the request has expired, has already been completely fulfilled or has been otherwise stopped or disabled. (Not used for 'suspended' orders.) \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0TIMING	event timing incorrect alert		Definition:The therapy is being performed at a time which diverges from the time the therapy was requested \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0MINFREQ	too soon within frequency based on the usage		Definition:The therapy action is being performed too soon after the previous occurrence based on the requested frequency \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0INTERVAL	outside requested time		Definition:The therapy action is being performed outside the bounds of the time period requested \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0NOTEQUIV	not equivalent alert		Definition:The therapy being performed is not sufficiently equivalent to the therapy which was requested. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0NOTEQUIVGEN	not generically equivalent alert		Definition:The therapy being performed is not generically equivalent (having the identical biological action) to the therapy which was requested. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0NOTEQUIVTHER	not therapeutically equivalent alert		Definition:The therapy being performed is not therapeutically equivalent (having the same overall patient effect) to the therapy which was requested. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0HELD	held/suspended alert		Definition:There should be no actions taken in fulfillment of a request that has been held or suspended. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ALLDONE	already performed		Definition:The requested action has already been performed and so this request has no effect \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0TOOSOON	Refill Too Soon Alert		The patient is receiving a subsequent fill significantly earlier than would be expected based on the amount previously supplied and the therapy dosage instructions \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ActFinancialDetectedIssueCode	ActFinancialDetectedIssueCode	inactive	Identifies types of detected issues for Act class "ALRT" for the financial acts domain. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ClinicalActionDetectedIssueCode	ClinicalActionDetectedIssueCode		Identifies types of issues detected regarding the performance of a clinical action on a patient. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0CAREGAP	Caregap		Identifies the type of detected issue is a care gap \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0CODINGGAP	Codinggap		Identifies the type of detected issue is a risk adjustment coding gap \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0ADVERSE_REACTION	Adverse Reaction		Indicates that the observation is of an unexpected negative occurrence in the subject suspected to result from the subject's exposure to one or more agents. Observation values would be the symptom resulting from the reaction. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0CTMO	case transmission mode observation		An observation that states the mechanism by which disease was acquired by the living subject involved in the public health case. \n OpenIssue: This code could be moved to LOINC if it can be done before there are significant implemenations using it. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0KSUBJ	knowledge subject		Categorization of types of observation that capture the main clinical knowledge subject which may be a medication, a laboratory test, a disease. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0KSUBT	knowledge subtopic		Categorization of types of observation that capture a knowledge subtopic which might be treatment, etiology, or prognosis. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ActPrivilegeCategorizationType	ActPrivilegeCategorizationType	inactive	This domain includes observations used to characterize a privilege, under which this additional information is classified. \n Examples:A privilege to prescribe drugs has a RESTRICTION that excludes prescribing narcotics; a surgical procedure privilege has a PRE-CONDITION that it requires prior Board approval. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_FDALabelData	FDALabelData	inactive	FDA label data \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FDASHAPE	shape	inactive	FDA label shape \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FDAIMPRINTCD	imprint code	inactive	FDA label imprint code \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FDALOGO	logo	inactive	FDA label logo \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FDACOATING	coating	inactive	FDA label coating \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FDASCORING	scoring	inactive	FDA label scoring \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FDASIZE	size	inactive	FDA label size \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0FDACOLOR	color	inactive	FDA label color \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ObservationQueryMatchType	ObservationQueryMatchType	inactive	Definition: An observation related to a query response. \n Example:The degree of match or match weight returned by a matching algorithm in a response to a query. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_ObservationIssueTriggerMeasuredObservationType	ObservationIssueTriggerMeasuredObservationType	inactive	Distinguishes between the kinds of measurable observations that could be the trigger for clinical issue detection. Measurable observation types include: Lab Results, Height, Weight. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_SimpleMeasurableClinicalObservationType	SimpleMeasurableClinicalObservationType	inactive	Types of measurement observations typically performed in a clinical (non-lab) setting. E.g. Height, Weight, Blood-pressure \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0_PreferenceObservationType	_PreferenceObservationType		Types of observations that can be made about Preferences. \n
`http://terminology.hl7.org/CodeSystem/v3-ActCode`	\u00a0\u00a0PREFSTRENGTH	preference strength		An observation about how important a preference is to the target of the preference. \n